Bioceres Crop Solutions (BIOX) Current Deferred Revenue (2016 - 2026)

Bioceres Crop Solutions has disclosed Current Deferred Revenue across 11 years of filings, most recently posting $2.8 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $2.8 million, down 27.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (down 27.5% YoY), and the FY2025 annual result was $4.3 million, up 120.39% from the prior year.
• Current Deferred Revenue came in at $2.8 million for Q1 2026 at Bioceres Crop Solutions, up from -$1.4 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $53.8 million in Q4 2022 to a low of -$1.4 million in Q4 2025.
• The 5-year median for Current Deferred Revenue is $3.9 million (2025), against an average of $9.9 million.
• Across the five-year window, Current Deferred Revenue soared 7114.03% in 2022 and slumped 147.83% in 2025, its largest moves.
• Bioceres Crop Solutions' Current Deferred Revenue stood at $53.8 million in 2022, then slumped by 58.9% to $22.1 million in 2023, then plunged by 86.74% to $2.9 million in 2024, then tumbled by 147.83% to -$1.4 million in 2025, then soared by 299.81% to $2.8 million in 2026.
• The last three Current Deferred Revenue figures came in at $2.8 million (Q1 2026), -$1.4 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.